ER^þ Breast cancers resistant to prolonged neoadjuvant letrozole exhibit an e2f4 transcriptional program sensitive to cdk4/6 inhibitors

Angel L. Guerrero-Zotano, Thomas P. Stricker, Luigi Formisano, Katherine E. Hutchinson, Daniel G. Stover, Kyung Min Lee, Luis J. Schwarz, Jennifer M. Giltnane, Monica V. Estrada, Valerie M. Jansen, Alberto Servetto, Joaquín Gavila, J. Perez Fidalgo Alejandro, Ana Lluch, Antonio Llombart-Cussac, Mohamed Amine Bayar, Stefan Michiels, Fabrice Andre, Monica Arnedos, Vicente GuillemAmparo Ruiz-Simon, Carlos L. Arteaga

Simmons Comprehensive Cancer Center - Administration - Directors Office - Administration
Simmons Comprehensive Cancer Center

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Fingerprint Dive into the research topics of 'ER<sup>þ</sup> Breast cancers resistant to prolonged neoadjuvant letrozole exhibit an e2f4 transcriptional program sensitive to cdk4/6 inhibitors'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

ERþ Breast cancers resistant to prolonged neoadjuvant letrozole exhibit an e2f4 transcriptional program sensitive to cdk4/6 inhibitors

Medicine & Life Sciences

ER^þ Breast cancers resistant to prolonged neoadjuvant letrozole exhibit an e2f4 transcriptional program sensitive to cdk4/6 inhibitors